Roles of RIPK3 in necroptosis, cell signaling, and disease

MJ Morgan, YS Kim - Experimental & molecular medicine, 2022 - nature.com
Abstract Receptor-interacting protein kinase-3 (RIPK3, or RIP3) is an essential protein in the
“programmed” and “regulated” cell death pathway called necroptosis. Necroptosis is …

[HTML][HTML] Life and death by death receptors

ME Guicciardi, GJ Gores - The FASEB Journal, 2009 - ncbi.nlm.nih.gov
Death receptors are members of the tumor necrosis factor receptor superfamily
characterized by a cytoplasmic region known as the “death domain” that enables the …

Apoptosis and cancer: mutations within caspase genes

S Ghavami, M Hashemi, SR Ande… - Journal of medical …, 2009 - jmg.bmj.com
The inactivation of programmed cell death has profound effects not only on the development
but also on the overall integrity of multicellular organisms. Beside developmental …

Lymphocyte-mediated cytotoxicity

JH Russell, TJ Ley - Annual review of immunology, 2002 - annualreviews.org
Virtually all of the measurable cell-mediated cytotoxicity delivered by cytotoxic T
lymphocytes and natural killer cells comes from either the granule exocytosis pathway or the …

Hepatocyte death: a clear and present danger

H Malhi, ME Guicciardi, GJ Gores - Physiological reviews, 2010 - journals.physiology.org
The hepatocyte is especially vulnerable to injury due to its central role in xenobiotic
metabolism including drugs and alcohol, participation in lipid and fatty acid metabolism, its …

Onto better TRAILs for cancer treatment

D de Miguel, J Lemke, A Anel, H Walczak… - Cell Death & …, 2016 - nature.com
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), also known as Apo-
2 ligand (Apo2L), is a member of the TNF cytokine superfamily. By cross-linking TRAIL …

Mechanisms of resistance to TRAIL-induced apoptosis in cancer

L Zhang, B Fang - Cancer gene therapy, 2005 - nature.com
The tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is regarded as a
potential anticancer agent. However, considerable numbers of cancer cells, especially some …

Apoptosis-based therapies

JC Reed - Nature reviews Drug discovery, 2002 - nature.com
Many of today's medical illnesses can be attributed directly or indirectly to problems with
apoptosis—a programmed cell-suicide mechanism. Disorders in which defective regulation …

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity

K Ichikawa, W Liu, L Zhao, Z Wang, D Liu, T Ohtsuka… - Nature medicine, 2001 - nature.com
A novel anti-human DR5 monoclonal antibody, TRA-8, induces apoptosis of most tumor
necrosis factor-related apoptosis-inducing ligand (TRAIL)-sensitive tumor cells both in vitro …

Tumor necrosis factor-induced nonapoptotic cell death requires receptor-interacting protein-mediated cellular reactive oxygen species accumulation

Y Lin, S Choksi, HM Shen, QF Yang, GM Hur… - Journal of Biological …, 2004 - ASBMB
The mechanism of tumor necrosis factor (TNF)-induced nonapoptotic cell death is largely
unknown, although the mechanism of TNF-induced apoptosis has been studied extensively …